Alidac Pharmaceuticals Limited, a amalgamated public limited company, was established on 14 October 2005 in Matoda, Gujarat, India. Engaging in pharma contract r&d within the manufacturing sector, it holds CIN: U24230GJ2005PLC046915. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹100.00 Cr and a paid-up capital of ₹99.33 Cr.
Formerly known as Zydus Bsv Pharma Private Limited., Alidac Pharmaceuticals Private Limited. It upholds a compliant status. Employing 242 professional, Its leadership includes Ganesh Narayan Nayak (Director), Kshitish Madanmohan Shah (Director), Subodhchandra Purushottamdas Adeshara (Director). Past directors included Ganesh Narayan Nayak, Kshitish Madanmohan Shah, Girish Bakre. It holds no open charges and ₹35.00 Cr settled loans. Its latest AGM occurred on 30 July 2019, with the balance sheet filed on 31 March 2019. It is based at Plot No. 1A, Pharmez, Sarkhej - Bavla N.H. No. 8A,, Matoda, Gujarat, 382213.
U24230GJ2005PLC046915
046915
14 October 2005
₹100.00 Cr
₹99.33 Cr
Roc Ahmedabad
Unlisted
Amalgamated
Explore comprehensive insights into Alidac Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganesh Narayan Nayak | Director | 07 Apr 2006 | Current |
| Kshitish Madanmohan Shah | Director | 27 Jul 2015 | Current |
| Subodhchandra Purushottamdas Adeshara | Director | 27 Jul 2015 | Current |
| Nitinkumar Dalsukhray Parekh | Director | 17 Jun 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Nominee Director | 25 Aug 2006 | Past |
| Pramod Abcsdd | Additional Director | 24 Sep 2015 | Past |
| Pramod Abcsdd | Director | 24 Mar 2015 | Past |
| Pramod Abcsdd | Director | 12 Jan 2017 | Past |
| Pramod Abcsdd | Nominee Director | 25 Aug 2006 | Past |
| Pramod Abcsdd | Director | 31 May 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alidac Pharmaceuticals Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 59.96% decrease. The company also saw a substantial fall in profitability, with a 188.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Alidac Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹350,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Aug 2008 | Export-Import Bank Of India | ₹35.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Alidac Pharmaceuticals has a workforce of 242 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Alidac Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alidac Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Alidac Pharmaceuticals Limited last Annual general meeting of members was held on 30 Jul 2019 as per latest MCA records. was documented.
Alidac Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Ahmedabad. was recorded as a recent event.
The activity Satyanarayan Ramkishan Sathe was appointed as a CEO was appointed as a CEO on 30 Mar 2019 & has been associated with this company since 6 years 9 months . was completed.
Progress on Dhavlal Narendra Soni was appointed as a Company Secretary was appointed as a Company Secretary on 07 Feb 2019 & has been associated with this company since 6 years 11 months . was documented.
Jignesh Batukbhai Thosani was appointed as a CFO was appointed as a CFO on 01 Feb 2019 & has been associated with this company since 6 years 11 months . was recorded as a recent event.
Kshitish Madanmohan Shah was appointed as a Director was appointed as a Director on 27 Jul 2015 & has been associated with this company since 10 years 5 months . was recorded as a recent event.
The CIN of Alidac Pharmaceuticals Limited is U24230GJ2005PLC046915.
Alidac Pharmaceuticals Limited is headquartered at Plot No. 1A, Pharmez, Sarkhej - Bavla N.H. No. 8A,, Matoda, Gujarat, 382213.
Alidac Pharmaceuticals Limited was incorporated on 14 October 2005.
The current directors of Alidac Pharmaceuticals Limited are
The primary industry of Alidac Pharmaceuticals Limited is Manufacturing.
Alidac Pharmaceuticals Limited is unlisted.
The authorized capital of Alidac Pharmaceuticals Limited is ₹100.00 Cr, and the paid-up capital is ₹99.33 Cr.
The compliance status of Alidac Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX